Plecanatide
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 124 publications
Constipation with bloating: a clinical approach to evaluation and management.
Journal: Annals of medicine
Published: June 19, 2026
A targeted partial reduction cyanylation strategy coupled with HRMS for accurate disulfide bridge mapping in disulfide rich cyclic peptides.
Journal: Journal of chromatography. A
Published: April 17, 2026
Patients' Real-World Experiences With Pharmacologic Therapies for Irritable Bowel Syndrome With Constipation: A Mixed-Methods Analysis and Classification of Social Media and E-Forum Posts.
Journal: Neurogastroenterology and motility
Published: February 27, 2026
Plecanatide Is Efficacious in Women Aged 18 to 40 Years With IBS-C and Bloating: A Pooled Analysis of Two Phase 3, Randomized, Placebo-Controlled Trials.
Journal: Gastroenterology & hepatology
Published: February 02, 2026
Improvement in Health-Related Quality of Life in Adults With IBS-C Not Achieving Bowel Movement Frequency Criterion: Analysis of Two Phase 3 Plecanatide Trials.
Journal: Gastroenterology & hepatology
Published: February 02, 2026
Real-World Safety Analysis of the Constipation-Predominant IBS Treatment Options Linaclotide, Lubiprostone, Plecanatide, and Tenapanor.
Journal: Gastroenterology & hepatology
Published: February 02, 2026
Reconsidering Multisymptom Composite Endpoints in IBS-C Trials.
Journal: Journal of gastroenterology and hepatology
Published: January 08, 2026
Efficacy and safety of Guanylyl cyclase C agonists (linaclotide and plecanatide) in patients with irritable bowel syndrome with constipation: a systematic review and meta-analysis of randomized controlled trials.
Journal: Frontiers in pharmacology
Published: December 05, 2025
Irritable Bowel Syndrome with Constipation: Diagnosis and Multisymptom Management Beyond Abdominal Pain and Bowel Movement Frequency: A Review.
Journal: Advances in therapy
Published: November 21, 2025
Reconsidering Bloating as a Core Endpoint in IBS-C: Commentary on Brenner et al. (2025).
Journal: Journal of gastroenterology and hepatology
Published: November 12, 2025
Based on the FDA Adverse Event Reporting System Database, a Study on Signal Mining of Adverse Events for Guanylate Cyclase-C Receptor Agonists.
Journal: Hospital pharmacy
Published: October 16, 2025
Laxative logic: when lifestyle is not enough.
Journal: Current opinion in gastroenterology
Published: September 29, 2025
Last Updated: 09/26/2026